SALT LAKE CITY, May 18, 2011 /PRNewswire/ -- USANA Health Sciences, Inc. (NYSE: USNA) today announced plans to expand intoThailand in the fourth quarter of 2011. This will be USANA's 16th market in which independent distributors sell USANA's high quality, science-based products.
Dave Wentz, USANA's Chief Executive Officer, said "We're very excited about our choice to enter the Thailand market, given that Thailand is one of the top markets in the world for businesses like USANA. We currently have leaders and customers, with existing ties to this country, who are confident that USANA will succeed in this growing market. Perhaps most importantly, we are confident that we will be able to expand into Thailand and still maintain focus on our primary expansion objective, which is growing USANA through BabyCare in China."
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, China, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
Investors Contact: Patrique RichardsInvestor Relations(801) [email protected]
Media Contact: Dan MacugaVice President of Marketing & Public RelationsUSANA Health Sciences, Inc.(801) [email protected]
SOURCE USANA Health Sciences, Inc.
Subscribe to our Free Newsletters!
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.